After millions upon millions of procedures performed over the span of several decades, the safety of the implants used in breast augmentation and reconstructive surgeries have been thrust to the forefront of thought for both the medical community and the women who underwent the operations. For most women exploring the idea of implants in the late-20th to early-21st centuries, concerns over the procedure were limited to ...
Decades Later, Concern Over Breast Implant Safety Intensifies
Posted July 30, 2020 in Drug and Medical Device Lawsuits | Product News and Recalls
A trove of new documents finally made public show that Bayer did not report a significant number of the reports of injuries it received over its Essure contraceptive device. Touted as a safe alternative to surgical sterilization, Essure would, instead, leave tens of thousands of women with intense bleeding and unbearable pain.
A legal maneuver by advocacy group Public Justice led to the release of the information. The hundreds of ...
continue reading...Philadelphia IVC Filter Trial Results in $33 Million Verdict
Posted April 23, 2020 in Drug and Medical Device Lawsuits | IVC Filter Failure | Product News and Recalls
The first IVC filter lawsuit to be heard in Philadelphia’s Court of Common Pleas has resulted in a $33 million verdict in favor of the plaintiff in the case. The verdict is significant because the city’s Court of Common Pleas is hearing over 760 such cases as a part of its IVC filter mass tort program. Some 15,000 additional IVC filter lawsuits are pending in federal ...
Zantac, Ranitidine, NDMA, and You: What You Need to Know
Posted April 9, 2020 in Drug and Medical Device Lawsuits | Heartburn Medications and Kidney Damage | Product News and Recalls | Recall
2020 has not been kind to Sanofi’s flagship heartburn medication Zantac. When reports first surfaced of contamination of the medication with a known carcinogen, attention immediately turned to the labs that made ranitidine, the active ingredient in Zantac. It wasn’t until researchers discovered that Zantac could be producing the carcinogen itself that calls began for a recall of the drug. The mechanism that could lead to such an occurrence, however, has ...
Lawsuit Alleges Textured Breast Implant Cancer Risk Coverup at Allergan
Posted April 6, 2020 in Drug and Medical Device Lawsuits | Product Liability | Product News and Recalls
Much of the initial concern over textured breast implant associated cases of anaplastic large cell lymphoma started out focused on non-U.S. markets. While the vast majority of U.S.-based breast implant procedures utilize smooth implants, the opposite held true for much of the rest of the market.
Six U.S. women who had textured breast implants used in their augmentation procedures have sued Allergan over their increased cancer risk and allege ...
continue reading...Belviq Pulled from Shelves Over Concerns of Cancer Risk
Posted March 12, 2020 in Drug and Medical Device Lawsuits | Product News and Recalls
Sales of weight-loss drug Belviq were halted earlier this month after research indicated that it could cause an increased risk of cancer. The drug had been sold in the United States since it was originally approved in 2012. Manufactured by Japanese pharmaceutical company Eisai Co., Belviq was designed to induce signals in the body and brain that told the patient he or she was full, thus causing them to eat less. ...
